News and media

Bowel cancer is the third most commonly diagnosed cancer in Australia and the second leading cause of cancer-related death. It claims the lives of over 5,000 Australians a year. Regular screening is important to detect it early, so take the free bowel cancer test – it could save your life.

The Australian Government Chief Medical Officer, Professor Paul Kelly, to lift the COVID-19 hotspot declaration of the Greater Melbourne area, from 11:59 pm 10 June 2021.

The Infection Control Expert Group (ICEG) and National COVID-19 Clinical Evidence Taskforce have jointly agreed on updated recommendations to protect healthcare workers from COVID-19 infection. This includes advice on when to use face (surgical) masks, P2/N95 respirators and eye protection.

A joint statement from Professor Paul Kelly, Australian Government Chief Medical Officer and Professor Alison McMillan, Australian Government Chief Nursing and Midwifery Officer

The Australian Technical Advisory Group on Immunisation has issued updated advice on the relative timing of administering influenza vaccines and COVID-19 vaccines in 2021.

Joint statement between RANZCOG and ATAGI about COVID-19 vaccination for pregnant women.

Medical Research Future Fund (MRFF) Projects highlights the work of some of our best and brightest researchers.

Australian Health Protection Principal Committee (AHPPC) statement on managed quarantine for international arrivals including hotel quarantine.

More people in Australia will be offered a safe and effective COVID-19 vaccine from next week. Find out more.

Read the Prime Minister’s update following the National Cabinet meeting on 4 June 2021.

Your phenome is a dynamic fingerprint of your unique biology. The Australian National Phenome Centre (ANPC) studies phenomes to better understand diseases and an individual’s disease risk.

More people in Australia will be offered a COVID-19 vaccine from next week.

Infants with hearing impairment can struggle to learn language and engage fully with the world around them. But a new clinical tool – EarGenie™ – promises to give them a head start soon after birth.

The Zero Childhood Cancer Personalised Medicine Program (ZERO) is helping to improve survival outcomes for kids most at risk.

Researchers tested a drug that could help to treat Motor Neurone Disease (MND). Thanks to donors and almost $2 million in MRFF funding, the trial was run at 6 centres.

Mackenzie's Mission is a ground-breaking initiative which identifies the risk of having a child with a genetic condition.